JNJ vs IDXX
By Alex · Tickerpine
Johnson & Johnson vs IDEXX Laboratories, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | IDXX |
|---|---|---|
| Price | $271.95 | $529.06 |
| Market cap | $655.37B | $41.68B |
| P/E ratio | 31.4 | 37.2 |
| ROE | 25.74% | 74.21% |
| Profit margin | 21.48% | 25.03% |
| Revenue growth | 6.60% | 9.70% |
| Dividend yield | 1.97% | — |
| Beta | 0.23 | 1.54 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs IDXX in plain English
- JNJ is the bigger company — about 15.7× the market cap of IDXX.
- JNJ is cheaper on earnings (P/E 31.4 vs 37.2).
- IDXX earns a higher return on equity (74% vs 26%).
- IDXX is growing revenue faster (10% vs 7%).
- JNJ pays a dividend (1.97%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
IDXX return calculator
See what $1,000 in IDEXX Laboratories, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.